Tag Archives: FOLFOX

New Treatment for Colorectal Cancer Patients with Liver Metastases

Posted on April 3, 2011 by wngai

In the past, bevacizumab (Avastin) plus FOLFOX (leucovorin, 5-fluorouracil, and oxaliplatin) is the mainstay treatment for colorectal cancer patients with metastases (Stage IV). Even though the response rate of this regimen is impressive, less than 10% of Stage IV colorectal cancer … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged 5-Fluorouracil, Avastin, bevacizumab, chemotherapy, FOLFOX, leucovorin, metastatic colorectal cancer, oxaliplatin, radiofrequency ablation, RFA, Survival | Comments Off